Billroth I (n = 103) | Gastric antrum cancer (n = 103) | Gastroduodenal ulcer (n = 0) | ||
Stage I | 63 (61.2%) | |||
Stage II | 40 (38.8%) | |||
Billroth II (n = 190) | Gastric antrum cancer (n = 159) | Gastroduodenal ulcer (n = 31) | ||
Stage I | 9 (5.7%) | Gastric ulcer | 2 (6.5%) | |
Stage II | 62 (39.0%) | Duodenal ulcer | 29 (93.5%) | |
Stage III | 88 (55.3%) | |||
Roux-en-Y (n = 101) | Gastric corpus cancer (n = 89) | Gastric cardia cancer (n = 12) | ||
Stage I | 1 (1.1%) | Stage II | 2 (16.7%) | |
Stage II | 46 (51.7%) | Stage III | 10 (83.3%) | |
Stage III | 42 (47.2%) |